These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19463347)

  • 1. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.
    Nishigaki K; Yamazaki T; Kitabatake A; Yamaguchi T; Kanmatsuse K; Kodama I; Takekoshi N; Tomoike H; Hori M; Matsuzaki M; Takeshita A; Shimbo T; Fujiwara H;
    JACC Cardiovasc Interv; 2008 Oct; 1(5):469-79. PubMed ID: 19463347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should percutaneous revascularization for stable coronary artery disease be performed sooner or later?
    Prasad A; Gersh BJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):480-2. PubMed ID: 19463348
    [No Abstract]   [Full Text] [Related]  

  • 3. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical therapy].
    Nishigaki K
    Nihon Rinsho; 2011 Feb; 69(2):253-8. PubMed ID: 21387672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes N; Gersh BJ; Soares PR; Ribeiro EE; Pereira AC; Favarato D; Rocha AS; Hueb AC; Ramires JA
    Circulation; 2010 Sep; 122(10):949-57. PubMed ID: 20733102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.
    Aksoy O; Tuzcu EM; Ellis SG; Whitlow PL; Cam A; Batizy L; Agarwal S; Franco I; Bajzer C; Simpfendorfer C; Raymond R; Nair R; Cho L; Shishehbor MH; Lincoff AM; Kapadia SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E1-8. PubMed ID: 22508442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention versus medical therapy in stable coronary artery disease: the unresolved conundrum.
    Epstein SE; Waksman R; Pichard AD; Kent KM; Panza JA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):993-8. PubMed ID: 24156960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
    Yasuda K; Kasuga H; Aoyama T; Takahashi H; Toriyama T; Kawade Y; Iwashima S; Yamada S; Kawahara H; Maruyama S; Yuzawa Y; Ishii H; Murohara T; Matsuo S
    J Am Soc Nephrol; 2006 Aug; 17(8):2322-32. PubMed ID: 16837633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.
    Stergiopoulos K; Brown DL
    Arch Intern Med; 2012 Feb; 172(4):312-9. PubMed ID: 22371919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
    Simoons ML; Windecker S
    Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial.
    Lima EG; Hueb W; Garcia RM; Pereira AC; Soares PR; Favarato D; Garzillo CL; D'Oliveira Vieira R; Rezende PC; Takiuti M; Girardi P; Hueb AC; Ramires JA; Kalil Filho R
    Am Heart J; 2013 Aug; 166(2):250-7. PubMed ID: 23895807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.
    Alcock RF; Yong AS; Ng AC; Chow V; Cheruvu C; Aliprandi-Costa B; Lowe HC; Kritharides L; Brieger DB
    Int J Cardiol; 2013 Aug; 167(4):1343-6. PubMed ID: 22534045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
    Katritsis DG; Ioannidis JP
    Circulation; 2005 Jun; 111(22):2906-12. PubMed ID: 15927966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.